BPM
ABBV icon

Bowling Portfolio Management’s AbbVie ABBV Stock Holding History

Bowling Portfolio Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.07M Sell
15,450
-11,066
-42% -$1.59M 0.57% 50
2022
Q2 		$4.06M Sell
26,516
-1,120
-4% -$171K 1.02% 21
2022
Q1 		$4.48M Sell
27,636
-1,678
-6% -$244K 0.96% 20
2021
Q4 		$3.97M Sell
29,314
-481
-2% -$56.8K 0.82% 20
2021
Q3 		$3.21M Buy
29,795
+73
+0.2% +$8.34K 0.72% 26
2021
Q2 		$3.35M Sell
29,722
-227
-0.8% -$25.6K 0.75% 24
2021
Q1 		$3.24M Buy
29,949
+4,800
+19% +$513K 0.77% 25
2020
Q4 		$2.69M Sell
25,149
-1,995
-7% -$192K 0.63% 30
2020
Q3 		$2.38M Buy
27,144
+21,006
+342% +$1.98M 0.53% 35
2020
Q2 		$603K Buy
6,138
+1,952
+47% +$172K 0.13% 208
2020
Q1 		$319K Buy
4,186
+24
+0.6% +$2.04K 0.08% 283
2019
Q4 		$369K Sell
4,162
-19
-0.5% -$1.58K 0.06% 289
2019
Q3 		$317K Sell
4,181
-46,875
-92% -$3.21M 0.05% 304
2019
Q2 		$3.71M Sell
51,056
-816
-2% -$64.1K 0.61% 39
2019
Q1 		$4.18M Sell
51,872
-13,073
-20% -$1.07M 0.66% 27
2018
Q4 		$5.99M Sell
64,945
-3,890
-6% -$342K 1.06% 11
2018
Q3 		$6.51M Buy
68,835
+2,110
+3% +$200K 0.91% 14
2018
Q2 		$6.18M Sell
66,725
-733
-1% -$71.6K 0.86% 18
2018
Q1 		$6.38M Buy
67,458
+15,541
+30% +$1.71M 0.87% 16
2017
Q4 		$5.02M Buy
51,917
+45,886
+761% +$4.32M 0.67% 31
2017
Q3 		$536K Buy
+6,031
New +$459K 0.08% 291
2013
Q3 		– Sell
-50,275
Closed -$2.08M – 104
2013
Q2 		$2.08M Buy
+50,275
New +$2.2M 0.61% 67

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bowling Portfolio Management's ABBV Position: Q3 2022 in Review

Bowling Portfolio Management reduced its AbbVie (ABBV) stake by 42% in Q3 2022, selling an estimated $1.59M and leaving 15,450 shares worth $2.07M. The position accounts for 0.57% of the portfolio, ranked #50.

Bowling Portfolio Management first reported a position in ABBV in Q2 2013 and has held it in 22 quarters since. The position peaked at $6.51M in Q3 2018. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • Bowling Portfolio Management held 15,450 shares of AbbVie worth $2.07M as of Q3 2022.
  • Bowling Portfolio Management sold 11,066 AbbVie shares in Q3 2022, an estimated $1.59M.
  • AbbVie made up 0.57% of Bowling Portfolio Management's portfolio in Q3 2022, its #50 holding.
  • Bowling Portfolio Management first reported a position in AbbVie in Q2 2013 and has held it in 22 quarters since.
  • Bowling Portfolio Management's AbbVie position peaked at $6.51M in Q3 2018.
  • 2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Bowling Portfolio Management's 13F filing for Q3 2022, filed 4 Oct 2022.